Keynote Speakers
Calvin Mak
Hospital Authority, Hong Kong
Dr Calvin Mak is a consultant neurosurgeon at Queen Elizabeth Hospital, Hong Kong and is the Clinical Associate Professor (Honorary) of the Department of Surgery at the Chinese University of Hong Kong.
His main clinical interest is both endoscopic and complex skull base surgery. Dr Mak performed the first endoscopic transorbital surgery for brain tumor in Hong Kong and has organized dissection courses on endoscopic transorbital surgery. He has been invited as faculty and instructor for various international skull base courses and meetings.
Apart from regular publications, he is co-editor of a multidisciplinary skull base textbook, author of book chapters, and serves as editor and reviewer for various journals and currently serves as Vice President of Hong Kong Neurosurgical Society, First Vice-President of Hong Kong Neuro-oncology Society, Executive Board member of the Asian Congress of Neurological Surgeons, delegates to Executive Committee of AASNS and WFNS, council member of the China Greater Bay Area Neurosurgical Alliance.
He is passionate about integrating innovative technology into medical services. He is the Cluster Coordinator of Information Technology and Information Systems of Kowloon Central Cluster (KCC), chair of the KCC Innovation Research Committee and KCC Smart Hospital Management Committee. His team developed the first Hospital Command Centre in Hong Kong, which helped the hospitals combat the COVID-19 crisis and pioneered the adoption of 5G technology in clinical application. He also conducted research on artificial intelligence applications in brain imaging, clinical prediction, surgical robots and LLM application in healthcare.
Dr. Calvin Mak was awarded as the Ten Outstanding Young Persons in Hong Kong in 2022 and received Outstanding Team Awards (Team Leader) and Young Achiever Award of the Hospital Authority. He currently also serves on various statutory boards and advisory committees for the HKSAR Government.
Chung-mau Lo
Secretary for Health, Health Bureau Hong Kong
Professor Chung-mau Lo was appointed Secretary for Health on 1 July 2022. Before joining the Government, he was Hospital Chief Executive at The University of Hong Kong-Shenzhen Hospital, Chair of Hepatobiliary & Pancreatic Surgery at The University of Hong Kong and Director of Liver Transplantation Centre at Queen Mary Hospital.
Professor Lo has devoted himself to clinical work, teaching and scientific research in the field of hepatobiliary surgery for more than three decades. He is internationally renowned for his expertise in hepatobiliary surgery and liver transplantation. He has published over 600 original articles in refereed international journals and his H-index is 94. His pioneering work in adult right lobe living donor liver transplantation has revolutionised the practice of liver transplant world-wide and has put Hong Kong on the world map of liver transplant. He and his team were awarded China’s top national honour of First-class State Scientific and Technological Progress Award in 2005.
He was the President of the International Liver Transplantation Society and the International Society for Digestive Surgery. He has served in the editorial board of many prestigious journals, including the American Journal of Transplantation, Liver Transplantation, Surgery and the Annals of Surgery. He has been elected as an Honorary Fellow of the American Surgical Association, the American College of Surgeons, and Royal College of Surgeons in Ireland as well as an Honorary Member of the European Surgical Association.
Professor Lo served as the Hospital Chief Executive of The University of Hong Kong-Shenzhen Hospital from November 2016 to June 2022. Under the “One Country, Two Systems” strategy, he has actively leveraged the advantages of Shenzhen-Hong Kong cross-border collaboration to advocate “Green Healthcare Reform ” in public hospitals, and to promote medical integration in the Greater Bay Area. Under his leadership, the Hospital became the youngest High-level Hospital of Guangdong Province in 2018 and received Shenzhen Municipal City Mayor’s Quality Gold Award in 2020. The Hospital has been selected as a National High-Quality Development Hospital in 2021.
Erwin Loh
Calvary Health Care, Australia
Professor Erwin Loh is President Elect of the Royal Australasian College of Medical Administrators and Chief Medical Officer at Goulburn Valley Health, a public regional health service in Victoria. Prior to that, he was national Chief Medical Officer and Group General Manager Clinical Governance for St Vincent’s Health Australia, the nation’s largest not-for-profit health and aged care provider, including 6 public hospitals, 10 private hospitals and 23 aged care facilities. Before that, he was the Chief Medical Officer of Monash Health, Victoria’s largest health service, where he worked for ten years. And before that he was the Deputy Chief Medical Officer at the Peter MacCallum Cancer Centre for three years. And immediately prior to that, he worked as a full-time lawyer at Sparke Helmore for two years.
He is qualified in both medicine and law, with general and specialist registration as a medical practitioner (medical administration specialty) and is a barrister and solicitor of the Supreme Court of Victoria and High Court of Australia. He also has an MBA, Master of Health Service Management, and PhD.
He is currently a director on the board of the Royal Australasian College of Medical Administrators and the Presbyterian Ladies’ College. He has previously been a director on the boards of St Vincent’s Institute, Garvan Institute of Medical Research, Aikenhead Centre for Medical Discovery, Hudson Institute of Medical Research, Monash Health Research Precinct Pty Ltd, Australian Medical Association (Victoria) and Law Institute of Victoria. He is a Graduate and Fellow of the Australian Institute of Company Directors.
He is Professor at Monash University, where he leads the Clinical Leadership and Management Unit at the Monash Centre for Health Research and Implementation. He is Honorary Clinical Professor with the title of Professor at the Department of Medical Education, University of Melbourne. He is Honorary Professor at Macquarie University at the Centre for Health Systems and Safety Research.
He teaches and carries out research in health law, health management and clinical leadership. He has been an invited speaker at local and international conferences, published on health law, medical management, and health technology, and is a member of the Association of Professional Futurists, with an interest in medical futurology.
He received the Distinguished Fellow Award from RACMA in 2017 for “commitment to governance, research and publication”.
Jason Leitch
Senior Fellow, Institute for Healthcare Improvement (IHI), Scotland
Jason is a Senior Fellow at the Institute for Healthcare Improvement.
From January 2015 to May 2024 Jason was The National Clinical Director for the Scottish Government. He worked for Government from 2007 as the National Clinical Lead for safety and subsequently, for Quality.
The National Clinical Director is responsible for quality in the health and social care system, including patient safety and person-centred care, NHS planning, and implementing quality improvement methods across the government and the broader public sector.
He was appointed CBE in the 2019 Queen’s Birthday Honours.
He was elected to the US National Academy of Medicine in 2022, a rare accolade for a non US citizen.
He is an Honorary Professor at the University of Dundee and a Visiting Professor at the University of Strathclyde in Glasgow.
He was a 2005-06 Quality Improvement Fellow at IHI.
Jason is a non-executive Board member of the Medical and Dental Defence Union of Scotland, a Board member of The Nazareth Trust which runs an acute hospital providing care in Northern Israel and the West Bank and a trustee of the Indian Rural Evangelical Fellowship (UK) which runs a children’s’ home and schools in southeast India.
He qualified as a dentist in 1991 and was a clinical academic and Consultant Oral Surgeon in Glasgow. He has a doctorate from the University of Glasgow, a Masters in Public Health from Harvard and is a fellow of the three UK surgical Royal Colleges.
He is an internationally recognised speaker and adviser on health and care improvement, public health and has advised countries all over the world.
Joanna Pang
Chief Medical Information Officer, Hospital Authority, Hong Kong
Dr. Joanna PANG is the Chief Medical Informatics Officer of the Information Technology and Health Informatics Division at the Hospital Authority (HA), overseeing the development strategies and directions of various clinical IT systems in HA. As an Emergency Medicine Specialist, Dr. Pang believes clinicians should always uphold a patient-oriented value when delivering patient care professionally. She is responsible for coordinating and developing the technology strategy of the Clinical Management System (CMS), health care digital transformation and innovative technology applications, to support the overall development direction and service planning of the Hospital Authority. She also leads the medical informatics teams to assist the Health Bureau in promoting the Public-Private Electronic Health Record Sharing System (eHRSS) and the development of clinical information system of Department of Health. Through collaborating with clinicians, IT experts, executives and patients, she embraces innovative IT initiatives with data driven approaches to create new and enhanced healthcare service delivery models.
Joseph Sung
NanYang Technological University, Singapore
Professor Joseph J.Y. Sung, a distinguished medical researcher, earned his MB BS from The University of Hong Kong in 1983, later obtaining a PhD in biomedical sciences from the University of Calgary and an MD from The Chinese University of Hong Kong (CUHK). With fellowships from esteemed medical institutions worldwide, he is an Academician of the Chinese Academy of Engineering, the Eurasian Academy of Sciences, and a Founding Member of the Academy of Sciences of Hong Kong (ASHK).
Renowned in gastroenterology, Professor Sung’s seminal work includes proving the relationship between H. Pylori and peptic ulcer diseases. He pioneered antibiotic treatments for H. Pylori infection and innovative endoscopic procedures for ulcer bleeding, transforming global gastroenterological practices. His research now extends to the gut microbiome and AI in clinical medicine.
Professor Sung led groundbreaking colorectal cancer screening research in the Asia-Pacific, earning recognition like the Laurel Award from the Prevent Cancer Foundation (2008) and the Marshall and Warren Lecture Award (2009). Notably, he spearheaded efforts against Severe Acute Respiratory Syndrome (SARS) in 2003, recognized as an “Asian Hero” by Time Magazine.
Acknowledged with numerous awards, including the Silver Bauhinia Star (2004) and the World Outstanding Chinese Award (2013), Professor Sung’s contributions are acclaimed locally and internationally. He has authored over 1000 scientific articles and edited numerous medical textbooks, cementing his legacy in medical academia.
Lee Chien Earn
Deputy Group Chief Executive Officer, SingHealth, Singapore
Prof Lee, a Public Health physician by training, is currently the Deputy Group Chief Executive Officer, Regional Health System, SingHealth that seeks to enable the population in Eastern Singapore to keep well, get well and live well. He also Chairs the Planning Committee for the upcoming Eastern General and Community Hospitals. He was previously the Chief Executive Officer of Changi General Hospital, a 1000 bed acute teaching hospital. Prior appointments included senior leadership positions in the Ministry of Health Singapore where he was involved in the strategic development and improvement of healthcare services as well as health regulation and finance. Prof Lee is currently a Clinical Professor with the Duke-NUS Medical School and Adjunct Professor in the Saw Swee Hock School of Public Health, National University of Singapore, and the Singapore University of Technology and Design. He was also a member of international committees such as International Steering Committee, WHO Collaborating Centre for Patient Safety; Steering Committee, Asia-Pacific Observatory on Health Systems and Policies; Joint Commission International Standards Advisory Panel. Prof Lee co-edited Singapore’s Health Care System: What 50 Years Have Achieved (2015) and contributed the chapter on Strategies for Health Services in the Oxford Textbook of Global Public Health (6th edition).
Maureen Bisognano
President Emerita and Senior Fellow, Institute for Healthcare Improvement (IHI), USA
Maureen Bisognano, President Emerita and Senior Fellow, Institute for Healthcare Improvement (IHI), previously served as IHI’s President and CEO for five years, after serving as Executive Vice President and COO for 15 years.
She is a prominent authority on improving health care systems, whose expertise has been recognized by her elected membership to the National Academy of Medicine (IOM), among other distinctions. Ms. Bisognano advises health care leaders around the world, is a frequent speaker at major health care conferences on quality improvement and is a tireless advocate for change. She is an Instructor at the Harvard School of Public Health.
She chaired the Advisory Board of the Well Being Trust, co-chairs the Massachusetts Coalition for Serious Illness Care with Dr. Atul Gawande, and serves on the boards of the Commonwealth Fund, Indiana University Health and Nursing Now. Prior to joining IHI, she served as CEO of the Massachusetts Respiratory Hospital and Senior Vice President of The Juran Institute.
Tony Ko
Chief Executive, Hospital Authority, Hong Kong Special Administrative Region, Hong Kong
Dr Tony Ko graduated from the University of Hong Kong in 1990. Dr Tony Ko is a physician by background and a specialist in geriatric medicine. He is currently the Chief Executive of the Hong Kong Hospital Authority (HA). Dr Ko moved from clinical medicine to health services management in 2008 and served under various management offices in the HA Head Office until the appointment to Hospital Chief Executive of Pok Oi Hospital and Cluster Chief Executive of New Territories West Cluster in 2012 and 2014 respectively. He was then appointed as the Director of Cluster Services in 2018 prior to the appointment to his current position in August 2019. Dr Ko is now leading a workforce of about 90 000, and managing 43 hospitals and institutes to deliver public healthcare services in Hong Kong and serving our citizens.
Other Speakers
Alastair Mah
United Family Healthcare China
Professor Alastair Mah, Vice President of Medical Affairs at United Family Healthcare, leads all medical staff and clinical services, with clinical governance and academic governance responsibilities. Alastair has extensive hospital management experience in Australia and Hong Kong, including as Chief Medical Officer at major academic health services. He served on multiple Board of Directors, including the Royal Australasian College of Medical Administrators and Rural Workforce Agency of Victoria. He holds professorial positions with Deakin University, Chinese University of Hong Kong and Hong Kong University,
Anne Lee
The University of Hong Kong, Shenzhen Hospital
Dr. LEE is currently the:
• Deputy Hospital Chief Executive, and Chief of Service (Clinical Oncology Center),
University of Hong Kong-Shenzhen Hospital;
• Director, Shenzhen Hospital Accreditation Research Center;
• ISQua Expert, International Society for Quality in Health Care
• Vice-President, Shenzhen–Hong Kong Medical Specialist Training Center;
• Coordinator of the UICC TNM Global Advisory Group
Dr. LEE’s Previous Key Appointments include:
• Professor & Head of the Department of Clinical Oncology, University of Hong
Kong;
• Board of Director, Union for International Cancer Control (UICC);
• Vice president, Hong Kong College of Radiologists.
Her Research Field focused on Nasopharyngeal Cancer. She has received many International Honors.
Bill Wang
Patient Liason Advisory Group, Hong Kong
Bill Wang is a 2018 recipient of a combined kidney and liver transplant to treat his polycystic kidney and liver disease, which was diagnosed two decades earlier. A retired lawyer and corporate executive, he has been active in patient and carer well-being advocacy, healthcare policy and regulatory reform and organ donation promotion, assisting pro bono in legal and governance matters for NGOs, charities and patient groups. Bill chairs the Patient Liaison and Advisory Group of the International Society of Nephrology (ISN). He also serves on the governance bodies of the Hong Kong Kidney Foundation, Hong Kong Transplant Sports Association, and Hong Kong Chartered Governance Institute and the Safety and Quality Committee at Prince of Wales Hospital, Chinese University of Hong Kong. Bill is a keen observer of medical and surgical advancements in the treatment of kidney, liver and other disorders. As a patient and organ transplant recipient, he has the utmost respect for all healthcare professionals and is immensely grateful to organ donors and their families. He has insatiable drive to understand medical concepts, terminologies, physiologies, risk factors and clinical trials to effectively bridge the communication, knowledge and expectation gaps between patients, carer and their providers. Bill has been a sought-after patient voice both locally and internationally in professional journals, conferences, media and advisory bodies. He remains an active and forward-looking volunteer, leveraging his personal and professional experiences to promote healthy lifestyle, disease prevention, early detection and intervention, improved people care, increased social and mental health support and organ donation rate.
Christina Maw
Hospital Authority, Hong Kong
Dr Christina MAW is currently the Chief Manager (Transformation Services) of HA Head Office, responsible for overseeing the planning, implementation and review of public-private-partnership projects of HA. She is also supporting the Strategic Purchasing Office of the Health Bureau on public-private-partnership initiatives. Dr MAW is a Specialist in Public Health Medicine. Before taking up the current post, Dr MAW was the Hospital Chief Executive of Grantham Hospital & Tung Wah Hospital, and previously working as the Chief Manager in the HA Head Office responsible for the planning and implementation of elderly, rehabilitation services, palliative care and primary care services.
David Sun
Hospital Authority Hong Kong
David is a Neurosurgeon by training and is currently the Head of Hospital Authority Academy in Hong Kong. He was the Deputy Chief Hospital Executive of Princess Margaret Hospital and North Lantau Hospital, and the Hospital Chief Executive of North District Hospital in 2016 and 2018 respectively. Before becoming a full-time administrator, he contributed to various professional training curriculum and programmes design. He remains a strong advocator for multi-disciplinary simulation training to promote team work, especially for patient engagement and safety culture. He is also interested in developing innovative and digital learning platforms.
Dominique Allwood
Chief Medical Officer at UCLPartners & Director of Population Health at Imperial College Healthcare NHS Trust, England
Dr Dominique Allwood is Chief Medical Officer at UCLPartners, a large health innovation partnership across North London and Essex covering a population of 5 million people, 17 hospitals and 5 universities. Dominique is currently Director of Population Health, Imperial College Healthcare NHS Trust. She provides leadership and expertise on a range of areas including improving equity and population health, anchor institutions, environmental sustainability, clinical engagement, and quality improvement. A Consultant in Public Health Medicine by background, she is a medical leader with 20 years of experience in healthcare including NHS provider and commissioner organisations, management consultancy and think tanks. She is a medical leader & public health physician with over 20 years of experience. She is an international speaker and facilitator & has published over 35 papers on improving healthcare. She holds an MPH and is Associate Editor of BMJ Leader Journal, Board Member of The Patient Revolution & Scientific Advisory Committee member, THIS Institute, University of Cambridge. She is currently completing an MBA at Henley Business School.
Donald Li
Elderly Commission, Hong Kong SAR, Hong Kong
Dr Donald Li is a specialist in Family Medicine and private practice in Hong Kong, Shenzhen and Shanghai. He is the Chairman of Elderly Commission. He is the Past President of the World Organisation of Family Doctors (WONCA) and Censor of the Hong Kong College of Family Physicians. He is a Past President of Hong Kong Academy of Medicine. Dr Li is an active member of many Hong Kong governmental, non-government organization and public health bodies. He is the Chairman of the Board of Directors of the Hong Kong Sheng Kung Hui Welfare Council, Director of the Hong Kong St. John Ambulance Association, and Chairman of ACAN.
Fei-Chau Pang
Commissioner for Primary Healthcare HKSAR, Hong Kong
Dr PANG Fei Chau is the current Commissioner for Primary Healthcare, the Government of the Hong Kong Special Administrative Region Health Bureau. He is the president of the Hong Kong College of Community Medicine. Dr Pang is an experienced health service executive and have been the Head of Human Resources of the Hospital Authority to provide strategic advice and leadership to the HR function of over 40 public hospitals. He was appointed as the member of the Elderly Commission of the Government of the Hong Kong Special Administrative Region between 2015‐2019. He was the elected Council member of The University of Hong Kong in 2021/22.
Fiona Herco
Institute for Healthcare Improvement (IHI), Australia
Fiona is a Director at the Institute for Healthcare improvement. Her career in public health has spanned a diverse range of health service manager roles, fueled by a passion for improved health care systems. She commenced her career at the Royal Melbourne Hospital and NorthWestern Mental Health in the legal team moving to lead organisation-wide initiatives and programs including improvement and redesign, business planning and culture change. She then oversaw the Office of the Chief Executive as Chief of Staff. Fiona has worked within the Department of Premier and Cabinet in the role of Principal Advisor, responsible for progressing partnerships with private, public, not-for-profit and community biomedical organisations.
Gilberto Leung
Hong Kong Academy of Medicine
Professor Gilberto Leung is a neurosurgeon and holder of the endowed Tsang Wing-Hing Professorship in Clinical Neuroscience at the University of Hong Kong (HKU). He obtained his MBBS and LLB from the University of London; MS, PhD and MD from HKU; and LLM in Medical Law and Ethics with Distinction from the University of Edinburgh. He is President of the Hong Kong Academy of Medicine, Co-Director of the Centre for Medical Ethics and Law at HKU, and Associate Dean (Teaching & Learning) of his medical faculty.
Göran Henriks
Chief Executive of Learning and Innovation, Qulturum, Sweden
Göran Henriks has been Chief Executive of Learning and Innovation at The Qulturum in the County Council of Jönköping, Sweden, since 1997. Qulturum is a centre for quality, leadership and management development for the employees in the County and also for health care on a regional and national level.
Göran has nearly forty years’ experience of management in the Swedish Health Care system. He is a member of the Jönköping County Council top management and Strategic Group. The county are ranked among the best in Swedish care with regards to patient satisfaction, access, clinical performance, safety and costs.
Göran is a senior fellow of the Institute for Healthcare Improvement and is the chair of the Strategic Committee of the International Forum on Quality and Safety in Healthcare.
Jeffrey Lai
Hospital Authority, Hong Kong
Dr Jeffrey Lai is a specialist in Emergency Medicine. He has been working in Accident and Emergency Departments for more than 20 years in Hong Kong. Jeffrey also holds a Master in Public Administration from the University of Hong Kong. He is currently working as Chief Manager of the Quality and Standards Department in the Hospital Authority. He has been leading his team to establish quality standards for HA hospitals, including credentialing, informed consent, waiting times for outpatient services and elective services. His office is also responsible to plan, organize and implement hospital accreditation for HA hospitals.
Kai-Ming Chow
Hospital Authority, Hong Kong
Dr. Chow is a graduate from the Chinese University of Hong Kong and is now the Chief of Service in the Department of Medicine and Therapeutics, Prince of Wales Hospital. Dr. Chow obtained the Croucher Foundation Fellowship and had worked in the Artificial Cells and Organs Research Centre at McGill University, Montreal. Dr. Chow has combined his position as nephrologist with that of honorary teaching staff in the Prince of Wales Hospital. He is actively involved in student teaching, and works as Deputy Service Director (Quality & Safety) at the Prince of Wales Hospital. Dr. Chow has published more than 290 Indexed publications in peer review journals, over 110 of them being the first author. As of January 2024, his H-index is 54.
Karen Tam
Hospital Authority, Hong Kong
Ms. Karen TAM is a senior clinical psychologist and the head of Oasis – Center for Personal Growth and Crisis Intervention under the Corporate Clinical Psychology Services, Hospital Authority (HA). She is leading the development and delivery of psychological services and related mental health promotion campaign for staff across clusters and hospitals in HA, with the objective of enhancing staff’s psychological wellbeing and cultivating a caring culture within the institution. In her clinical practice, Ms. Tam is experienced in providing various evidence-based treatments and related training courses to support staff facing psychological distress or critical incidents (e.g. workplace violence, sudden death).
Kelvin Tsoi
"Associate Professor, The Chinese University of Hong Kong, Hong Kong
Professor Kelvin Tsoi is an Epidemiologist specialized in Digital Health. His research interests focus on digital innovation in chronic disease management, including mobile and telecare application for hypertension management, technological implementation and social engagement for cognitive screening, artificial intelligent application on electronic health records. He also works as the traditional epidemiologist on evidence- based medicine and population cohort studies. He is also the founder of DeepHealth, a start up to promote artificial intelligent applications of mobile devices for better health management. His team developed a mobile blood pressure management platform so users can easily manage personal health data through smart phones.
Kenneth Tsang
Chief Executive Officer, Gleneagles Hospital Hong Kong and Regional Chief Executive Officer, IHH Healthcare North Asia; Hong Kong
Dr Kenneth Tsang provides leadership for Gleneagles Hospital Hong Kong, a multi-specialty tertiary hospital under an international healthcare group IHH Healthcare. Dr Tsang leads the hospital to provide excellent and innovative healthcare services in Hong Kong and at a regional level. Dr Tsang also steers the hospital’s development in the realms of digital health, clinical innovations and clinical research to foster its growth into a leading healthcare provider locally and regionally.
Dr Tsang joined Gleneagles Hospital Hong Kong in 2019 as Chief Operating Officer and was appointed as its Chief Executive Officer in 2021.
Dr Tsang was appointed as Regional Chief Executive Officer of IHH Healthcare North Asia in 2024. In conjunction with his role as Chairman of IHH China Operations Steering Committee, he plays a pivotal role in advancing IHH’s operations in China towards long-term growth. He also leads Parkway Medical Services (Hong Kong) Limited, a member of IHH Healthcare, which operates Gleneagles Healthcare ambulatory centres and clinics and Parkway Laboratory Services in Hong Kong.
Prior to joining Gleneagles, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician in the Department of Medicine in Queen Elizabeth Hospital. In 2009, he took up part-time administrative roles at the Kowloon Central Cluster on top of his clinical duties. During the years between 2012 and 2019, he became a full-time medical administrator at the Hospital Authority Head Office, assuming management roles in various areas including Patient Safety, Strategy & Service Planning, Infection Control and Cluster Services.
Dr Tsang is a Fellow of the Hong Kong Academy of Medicine (Community Medicine), a Fellow of the Hong Kong College of Community Medicine and a Fellow of The Royal Australasian College of Medical Administrators. He is also an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine of The University of Hong Kong.
Larry Lee
Hospital Authority, Hong Kong
Dr Larry Lee is currently the Chief Manager, Cluster Performance, Hospital Authority Head Office (HAHO) with an emergency physician background. Dr Lee accomplished his basic medical qualification as well as his internship training in Sydney before he started his emergency medicine training in Hong Kong in 1998. Dr Lee attained his specialist status in 2004 followed by fruitful administrative exposures before and after his appointment as associate consultant in 2008. In 2016, Dr Lee participated in the commissioning of Tin Shui Wai Hospital (TSWH) and further appointed as the deputy hospital chief executive who contributed the service implementation of this 300-bed hospital. Adjunct with his participation in handling COVID-19 outbreak, he took up managerial roles as Chief Manager in HAHO who responsible for cluster performance and operation services.
Libby Lee
Under-Secretary for Health, Health Bureau Hong Kong
Dr. LEE is the Undersecretary of Health Bureau, the Hong Kong Special Administrative Region since July 2022. She was the Director of the Strategy and Planning Division at the Hospital Authority administration before the current position. The Hospital Authority provides public healthcare services to the 7 million Hong Kong population through 27,000 beds in 43 public hospitals. The scope of her works includes strategy, service, capital and annual planning for the whole Hospital Authority. The current projects include the Hong Kong Children’s Hospital, Queen Mary Hospital, United Christian Hospital, Kwong Wah Hospital, and the Hospital at Kai Tak etc.
She is trained as anaesthesiologist in Queen Mary Hospital focusing on liver transplantation, pain management, electronic anaesthetic record system and simulation training. In 2008, she started her career in administration, first in Patient Safety and Risk Management as the Head of the Patient Safety and Risk Management Department in the Hospital Authority administration. The Department identifies clinical risks through incident management and the annual risk registration exercises, through which corporate strategies and risk reduction programmes are formulated, and quality improvement programmes in individual hospitals and clusters are facilitated and monitored. She then works in the Division of Strategy and Planning for public healthcare services development since 2011. In 2015, she also takes up the position of Deputizing Hospital Chief Executive of the Buddhist Hospital, overseeing the operations of the hospital as well as its refurbishment works.
Maria Lyn Quintos-Alagheband
Chief, Quality and Safety Officer of Children's Services, Pediatrics, NYU Langone Hospital Long Island, USA
Lyn Quintos-Alagheband is a Board certified Pediatric Critical Care Physician, Quality Improvement Leader and Educator. She is currently the Chief Quality Officer for Children’s Services at NYU Langone Hospital–Long Island (NYULH-LI) and the Director of Health Systems Science for NYU Grossman LI School of Medicine.
Dr. Quintos-Alagheband graduated from the University of Santo Tomas Faculty of Medicine and Surgery. She completed her pediatric residency at New York University Medical Center, followed by Critical Care Medicine fellowship at the Children’s Hospital of Los Angeles. She then took on the role of Associate Director of Pediatric Critical Care at what is now NYULH-LI. Over her 15+-year experience at the bedside caring for critically ill patients, she developed a deep interest in Quality Improvement science leading her to complete the Greater NY Hospital Association Clinical Quality Fellowship Program.
Dr. Quintos-Alagheband holds a Black Belt certification in Lean Six Sigma (LSS). Her expertise includes the innovation, and execution of high-value Quality Improvement (QI) & Patient Safety projects, as well as the leadership of cross-functional teams. A highlight of her work includes pioneering the Key-card Change Program, a standardized, innovative model for patient and family engagement in patient safety that applies LSS principles. She is dedicated to transforming care delivery and culture through innovative solutions co-produced by patients and the frontline.
Dr. Quintos-Alagheband has held various leadership positions at the national and regional level in QI and Patient Safety in the United States. She serves as Chair of the New York State Pediatric Sepsis Advisory Taskforce and Regional Culture of Safety and High Reliability Subject Matter Expert for the Children’s Hospitals Solutions for Patient Safety Network.
As a pediatrician, an educator and a mother of two young adults, she takes great pride in mentoring the next generations of health leaders and change agents.
Raymond Cheung
Hospital Authority, Hong Kong
Dr. Raymond Cheung is currently the Chief Manager (Patient Safety & Risk Management), Hospital Authority. He has worked as Service Director (Quality & Safety) in Kowloon West Cluster and Deputy Hospital Chief Executive (Quality & Performance) in Princess Margaret Hospital. Dr. Cheung is a specialist in Critical Care Medicine and has completed master degree in Science in Epidemiology and Biostatistics. Over the years, he had led multiple projects related to quality improvement and workflow reengineering at hospital and cluster levels.
Samuel Wong
The Chinese University of Hong Kong, Hong Kong
Professor Samuel Wong is a clinician with training and experience in both Family Medicine and Public Health. Currently, Professor Wong serves as the Director of the School of Public Health and Primary Care and as the Associate Dean (Education) at the Faculty of Medicine at CUHK. Professor Wong has published over 370 peer-reviewed papers in international journals with his research interests primarily focused on the evaluation and development of mental health interventions in primary care and the evaluation of primary care services. Professor Wong has served the Hong Kong SAR Government in various capacities, including as a member of the Steering Committee of the Primary Care Development.
Sandy Choi
Hong Kong Metropolitan University, Hong Kong
Dr. Sandy Pin Pin Choi is a dedicated professional with expertise in the field of nursing education and nursing management. Holding a Ph.D. in Nursing, Dr. Choi currently serves as the Associate Dean (Global Partnership and Community Engagement) and Associate Professor at the School of Nursing and Health Studies, Hong Kong Metropolitan University. With a genuine passion for supporting student
learning and fostering a positive work environment for nurses, Dr. Choi has published several influential papers on nursing competencies. Through her dedicated work, she strives to make a meaningful impact in the field of nursing, inspiring future generations of healthcare professionals.
See Kee Fok
Senior Manager, Quality, Safety & Risk Management Department, Gleneagles Hospital Hong Kong
Sek Ying Chair
Hong Kong Academy of Nursing, Hong Kong
Professor Chair Sek-ying is the Vice-Director (Research) of the Nethersole School of Nursing at CUHK. She is a Fellow of American Academy of Nursing and a Co-Chair of ICN Advanced Practice Nursing Network. She is a Director of CUHK Medical Centre, and the Immediate Past President of HK Academy of Nursing and Midwifery.
Professor Chair has published over 200 peer-refereed papers and has been named among the World’s Top 2% Nursing Scientists by Standard University for 2021 and 2022. She is an Editorial Board Member of Asian Nursing Research, Journal of Research in Nursing and International Journal of Nursing Sciences.
Shin Ushiro
Professor, Kyushu University Hospital, Japan
Prof Shin Ushiro works as a deputy director of and divisional director of the Division of Patient Safety in Kyushu University Hospital, Japan. At institutional level he has engaged in wide range of quality and safety initiatives such as incident reporting system, hospital accreditation, conflict mitigation through candid communication with patient and family. Dr. Ushiro also works in the Japan Council for Quality Health Care (JQ) which has project lines such as Hospital accreditation, National adverse event reporting and learning system, No-fault compensation system for cerebral palsy. JQ is an influential body over quality and safety improvement across healthcare sector in his country. As such, his activities extend to a national level. Furthermore, at international level, he worked as a board member of ISQua (International Society for Quality in Healthcare) during 2017-2024 which provides global opportunities of conference, education, external evaluation. He still works for ISQua as a member of Accreditation Council which is one of the most important committees in ISQua. In addition, he has been working as a steering committee member of the serial Global Ministerial Summit on Patient Safety. He also serves as a member of the G20 Patient Safety Leaders Group. Who is engaged in those activities which are valued opportunities for Dr Ushiro to work with WHO.
Stephanie Easthope
Institute for Healthcare Improvement (IHI), Australia
Stephanie is a Project Director for IHI and is currently working with the Victorian Department of Health on the Timely Emergency Care Collaborative. Stephanie has worked in service design and improvement for more than 20 years, and through this time has completed a Lean Six Sigma Black Belt, the IHI Improvement Advisor Program, IHI Innovation College, and Lean Coach (Cardiff University) qualifications. She has worked across the NZ health sector as a Principal consultant, as a Design Lead at the New Zealand (NZ) Accident Compensation Corporation, and as a improvement manager and faculty at Ko Awatea, a healthcare innovation and improvement centre in Auckland. She has supported seven District Health Boards in NZ to improve patient flow and has delivered improvement science training and coaching for leaders and teams across the health sector.
Susanne Mak So Shan
Oncology Nurse Consultant, Hospital Authority, Hong Kong
Ms Mak is currently Oncology Nurse Consultant in Hospital Authority, the Co-opted Member of the Accreditation Committee in Nursing Council of Hong Kong, and the Vice President in HK College of Medical Nursing.
She has extensive experience in oncology and apheresis nursing that make up her expertise to help new rapid development of cellular therapy in the field. She has multiple publications, including papers reflecting her series of research work on both specialty and generic clinical practice, and her endeavor on quality and patient care improvement. She has also gained various awards including research grants, Asian Hospital Management Awards for her leading clinical quality improvement project, etc.
Sylvia FUNG Yuk Kuen
The Hong Kong Academy of Nursing & Midwifery, Hong Kong
Professor Fung has extensive experience in clinical practice, education and management of nursing. She has been the Chief Manager (Nursing) of Hospital Authority (HA) taking charge of more than 20,000 nurses. She was awarded the prestigious Florence Nightingale Medal in 2005 by the International Red Cross for her commitment and contribution to nursing services and mankind. She is currently a member of the Complaint Committee of the Private Healthcare Facilities and also a member of the Public Complaint Committee of the Hong Kong Hospital Authority.
Tang Kong Choong
CEO, Tan Tock Seng Hospital, Singapore
Dr Tang is the CEO of TTSH – the flagship hospital of the National Healthcare Group (Singapore). With more than 2200 beds on HealthCity Novena Campus, TTSH serves the healthcare needs of 1.4 million residents in Central Singapore. As CEO, Dr Tang drives the hospital’s long term plan to achieve excellence in Tertiary Care and Academic Health, enabled through digital and workforce transformation and also redevelopment of the Campus, as part of Phase 2 of the HealthCity Novena Masterplan.
Tse Man Li
Hong Kong Poison Centre, Hong Kong
Dr Tse is a clinical toxicologist and an emergency physician in Hong Kong. He has a keen interest in the safety of Chinese medicine (CM) and has been involved in the development of quality and safety policies for the management of herbs in HA tripartite CM clinics. Since 2014, he serves as the co-chairman of the Expert Panel on Herb Safety for the Integrated Chinese and Western Medicine (ICWM) programme. In 2023, the ICWM Treatment Safety Centre was established under the Hong Kong Poison Control Centre to focus the effort in HA and to collaborate with external stakeholders to advance the science and art of ICWM safety. Dr Tse is an Adjunct Associate Professor of the Hong Kong Institute of Integrative Medicine, CUHK and a member of the Chinese Medicine Development Committee of HKSAR.
T Y Chan
Hospital Authority, Hong Kong
Dr Chan Tak Yeung graduated from the University of Hong Kong and completed his specialist training in Geriatric Medicine and Internal Medicine at Kwong Wah Hospital. Currently, he is Consultant in charge of Geriatric Unit and also Deputy Chief of Service(Training) in the Department of Medicine and Geriatrics of Kwong Wah Hospital. Dr Chan is also the Chairman of Specialty Board in Geriatric Medicine in Hong Kong College of Physicians and Co-Chairman of Geriatric Subcommittee in Hospital Authority. He is also Honorary Clinical Associate Professors in the Faculty of Medicine of HKU and CUHK.
Victor Manvir
Chairman, Patients for Patient Safety, Malaysia
Manvir Victor is a kidney disease patient and received a kidney transplant in 2012. Manvir is the WHO chairman for patient safety in Malaysia, a member of the National Patient Safety Council and part of the British Medical Journal international patient panel as well as a member of the Patient Liaison Advisory Group of the ISN. He also hosts “Healthcare today with Manvir Victor, a podcast that reaches 15 countries. He’s available on X @manvirvictor.
Wing Cheung Leung
Hong Kong Academy of Medicine, Hong Kong
Dr. Wing Cheong LEUNG 梁永昌graduated from the Medical School of University of Hong Kong (HKU) in 1989. He has completed his specialist training in O&G in the Dept of O&G, Tsan Yuk Hospital & Queen Mary Hospital, HKU and become a specialist in O&G (HKAM) in 1997.
Thereafter he has subspecialized in Maternal Fetal Medicine (MFM) & undergone overseas training in the Perinatal Centre, University of Toronto, Canada in 1999 and the Fetal Medicine Centre, University College London, UK in 2002/3. He becomes an accredited subspecialist in MFM by RCOG (UK) in 2003 (1st one in HK) and by HKCOG in 2005. He got his MD (HKU) in 2010 with the thesis entitled: Rapid aneuploidy testing or traditional karyotyping, or both, in prenatal diagnosis.
He is awarded Honorary Fellow by HKCOG in 2022 and Outstanding Staff of Hospital Authority in 2024.
Wong Chi Yan
Associate Consultant, Grantham Hospital, Hong Kong
Dr. Wong Chi Yan is an associate consultant at the Palliative Care Unit at Grantham Hospital in Hong Kong. She is a graduate of the University of Hong Kong. She completed fellowship exams in medical oncology, palliative medicine, and advanced internal medicine. With her past expertise and experience, her special interest lies in providing palliative care services to oncology patients and patients with disabilities. She is also the doctor representative for the “Embracing the Setting Sun” project, a collaborative effort with the Tung Wah Group of Hospitals Jockey Club Rehabilitation Complex. This initiative aims to provide specialized palliative care services to patients with disabilities, ensuring compassionate and holistic support during their end-of-life journey.
Yanka Campbell
Quality Improvement & Patient Safety Professional, Oncology, Johns Hopkins, USA
Yanka Campbell, DNP, RN, AGPCNP-BC, CNE, is the Quality Improvement and Patient Safety Leader at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. In this role, she develops and manages complex improvement projects that address identified performance gaps, prevent patient harm, and improve outcomes. Her clinical experience is in acute oncology care, focusing on improving symptom management across the continuum of care. Dr. Campbell is the chair of the Comprehensive Cancer Center Consortium (C4QI) Bone Marrow Transplantation (BMT) and Immune Effector Cell Therapy (IEC) work Group. Dr. Campbell is also an adjunct faculty member at the University of Maryland School of Nursing (UMSON), where she teaches in the Master of Health Services Leadership and Management program. Before joining UMSON, she taught in the MSN (Entry into Nursing) Program at the Johns Hopkins University School of Nursing. In addition to her healthcare-related experiences, Dr. Campbell served in various leadership roles, directing administrative operations, including fiscal and budgetary management. Dr. Campbell received her Bachelor of Science in Accounting from Strayer University and a Master of Science in Nursing from the University of Maryland Baltimore. She ultimately received her Doctor of Nursing Practice (DNP) from the Johns Hopkins University School of Nursing. Dr. Campbell mentors DNP students through their scholarly projects and has presented several quality improvement projects at national conferences.